Pharmacy

Pharmacists with specialized training can now prescribe buprenorphine to treat opioid use disorder under a federal bill signed into law Dec. 1. The provision is part of the SUPPORT for Patients and Communities Reauthorization Act of 2025, and allows the…

CVS Pharmacy will pay $37.76 million to resolve allegations that it over-dispensed insulin pens and improperly billed federal health programs over a 10-year period. The settlement resolves claims that CVS pharmacies from 2010 to 2020 repeatedly refilled insulin prescriptions too…

For some hospitals and systems, pharmacy is the No. 1 revenue generator, but pharmacy department leaders say they’re often underutilized.  Darren Evans, PharmD, system vice president of pharmacy services and hospital operations at Albany, Ga.-based Phoebe Putney Health System, told…

New York City-based Mount Sinai Health System’s outpatient pharmacy is undergoing a major digital transformation, one that Senior Director of Outpatient Pharmacy Mark Makhinson, PharmD, said is redefining efficiency, patient experience and staff engagement. “We’re really moving toward a digital-first…

In a series of high-impact moves, the FDA is reshaping how it approves and regulates drugs, including accelerating reviews, revising vaccine standards and simplifying biosimilar development. Leadership driving these changes is also in flux: Richard Pazdur, MD, who was named director…

In a first, the World Health Organization has issued a guideline on GLP-1s, a drug class that up to 1 in 8 U.S. adults report using, according to KFF research.  The WHO’s guideline, published Dec. 1 in JAMA, recommends long-term…

Eli Lilly has lowered the price of its GLP-1 drug Zepbound (tirzepatide) in single-dose vials, with the starting dose now available for $299 per month through the company’s direct-to-consumer platform, LillyDirect. The drugmaker said in a Dec. 1 news release…

The U.S. and the United Kingdom reached an agreement in principle to address pharmaceutical pricing disparities and secure investment under the U.S.-U.K. Economic Prosperity Deal. According to a Dec. 1 news release from the U.S. trade representative’s office, the U.K.…

The $7.5 billion opioid settlement involving Purdue Pharma took a major step forward Nov. 14 after the U.S. Bankruptcy Court for the Southern District of New York said it will confirm the company’s reorganization plan. The plan had been pending…

A top FDA official has proposed broad changes to the review and approval process for vaccines, citing a new internal review linking the deaths of 10 children to COVID-19 vaccines.  In an internal memo to staff, Vinay Prasad, MD, the…